These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38428674)

  • 1. Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period.
    Murakami Y; Nozaki Y; Morosawa M; Toyama M; Ogashiwa H; Ueda T; Nakajima K; Tanaka R; Takesue Y
    J Infect Chemother; 2024 Sep; 30(9):853-859. PubMed ID: 38428674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the role of bacterial and fungal infection in COVID-19.
    Rawson TM; Wilson RC; Holmes A
    Clin Microbiol Infect; 2021 Jan; 27(1):9-11. PubMed ID: 32979569
    [No Abstract]   [Full Text] [Related]  

  • 4. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Clinical Impact of Viral and Bacterial Coinfections in Hospitalized Children and Adolescents Aged under 18 Years with COVID-19 during the Omicron Wave in Russia.
    Yakovlev AS; Afanasev VV; Alekseenko SI; Belyaletdinova IK; Isankina LN; Gryaznova IA; Skalny AV; Kozlovskaya LI; Ishmukhametov AA; Karganova GG
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
    Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
    Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?
    Owoicho O; Tapela K; Djomkam Zune AL; Nghochuzie NN; Isawumi A; Mosi L
    Future Microbiol; 2021 Aug; 16():919-925. PubMed ID: 34319168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are omicron infections more frequently associated with bacterial co-infections?
    Teymurlu F; Sarsilmaz YS; Güzel Aygören Ö; Gültekin B; Gül Ş; Suner A; Sayiner A
    Tuberk Toraks; 2024 Jun; 72(2):131-136. PubMed ID: 38869205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased antimicrobial resistance during the COVID-19 pandemic.
    Lai CC; Chen SY; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
    Liu HH; Yaron D; Piraino AS; Kapelusznik L
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
    Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
    Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study.
    Tsai YH; Hou TC; Liu PY; Chen CJ; Wang JM
    In Vivo; 2024; 38(4):1965-1972. PubMed ID: 38936952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.